scholarly journals Newer Stents for Unresectable Malignant Distal Biliary Obstruction: Striving for Perfection!

2021 ◽  
Vol 12 (01) ◽  
pp. 059-062
Author(s):  
Jimil Shah ◽  
Surinder Singh Rana

AbstractEndoscopic biliary stenting is one of the most commonly used palliative procedure in patients with unresectable malignant distal biliary obstruction. Biliary stenting can be performed with either plastic or metallic stents. Stent occlusion and migration are important limitations of currently available stents. Variety of newer stents with varying designs and stent materials like stents with antimigratory properties, antireflux stents, drug-eluting stents, radioactive stents, and bioabsorbable stents are being developed to overcome the limitations of currently available stents. In this article, we are discussing two articles on the newer stent designs (plastic and metal stents) for biliary drainage in patients with unresectable malignant distal biliary obstruction.

VASA ◽  
2012 ◽  
Vol 41 (2) ◽  
pp. 90-95 ◽  
Author(s):  
Rastan ◽  
Noory ◽  
Zeller

We have investigated the role of drug-eluting stents on patency rates after treatment of focal infrapopliteal lesions in patients with intermittent claudication and critical limb ischemia. Reports indicate that drug-eluting stents reduce the risk of restenosis after percutaneous infrapopliteal artery revascularization. A Pub Med, EMBASE, Cochrane database review search of non-randomized studies investigating patency rates, target lesion revascularisation rates, limb salvage rates and mortality rates in an up to 3-year follow-up period after drug-eluting stent placement was conducted. In addition, preliminary results of randomized studies comparing drug-eluting stents with bare-metal stents and plain balloon angioplasty in treatment of focal infrapopliteal lesions were included in this review. A total of 1039 patients from 10 non-randomized and randomized studies were included. Most commonly used drug-eluting stents were sirolimus-eluting. The mean follow-up period was 12.6 (range 8 - 24). The mean 1-year primary patency rate was 86 ± 5 %. The mean target lesion revascularization rate and limb salvage rate was 9.9 ± 5 % and 96.6 %±4 %, respectively. Results from non-randomized and preliminary results from prospective, randomized trials show a significant advantage for drug-eluting stents in comparison to plain balloon angioplasty and bare-metal stents concerning target lesion patency and in parts target lesion revascularisation. No trial reveals an advantage for drug-eluting stents with regard to limb salvage and mortality.


2008 ◽  
Vol 131 (1) ◽  
pp. e7-e9 ◽  
Author(s):  
Marco L. Rossi ◽  
Dennis Zavalloni ◽  
Gabriele L. Gasparini ◽  
Patrizia Presbitero

2011 ◽  
Vol 57 (14) ◽  
pp. E1184
Author(s):  
Pascha Schafer ◽  
Matthew T. Sacrinty ◽  
Michael A. Kutcher ◽  
Renato M. Santos ◽  
Sanjay K. Gandhi ◽  
...  

Open Heart ◽  
2016 ◽  
Vol 3 (2) ◽  
pp. e000445 ◽  
Author(s):  
Louise Baschet ◽  
Sandrine Bourguignon ◽  
Sébastien Marque ◽  
Isabelle Durand-Zaleski ◽  
Emmanuel Teiger ◽  
...  

2016 ◽  
Vol 57 (2) ◽  
pp. 150-157 ◽  
Author(s):  
Hiroshi Tamura ◽  
Katsumi Miyauchi ◽  
Tomotaka Dohi ◽  
Shuta Tsuboi ◽  
Manabu Ogita ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document